Psilocybin Therapy Canada
Psilocybin Therapy Canada cases, patients with a mental health or addictions challenge can receive psychedelics with the help of a trained therapist. This is known as psychedelic assisted therapy. The therapy typically involves a one-time dose of five to six grams of psilocybin—the psychedelic compound found in what are commonly called magic mushrooms—in tandem with therapeutic counselling and therapy before, during and after the experience. In Canada, this is only legal through the Special Access Program (SAP), a process that involves submitting an application to Health Canada, which then grants healthcare professionals access to legally obtain psilocybin from manufacturers in accordance with its requirements.
Psilocybin Therapy Canada: Exploring Psychedelic Healing Nationwide
Currently, this is the main pathway for healthcare professionals to provide psilocybin-assisted psychotherapy for their patients. It’s not an appropriate pathway for everyone, however. In 2022, Blue Cross Alberta became the first Canadian insurance company to include psilocybin-assisted therapy in its coverage, joining other Canadian insurers that already cover other “psychedelic” drugs including MDMA for PTSD and THC for pain relief.
Health Canada encourages Canadians seeking to alleviate enduring and intolerable psychological suffering associated with a life-threatening condition to discuss their options with their healthcare provider, including clinical trials and the SAP. The SAP and clinical trials have rigorous safeguards in place to protect patient safety, ensure the quality of the drug, and provide for administration and supervision by a healthcare professional.…
Read More »